291 related articles for article (PubMed ID: 15689493)
1. Cholesterol and fatty acids regulate dynamic caveolin trafficking through the Golgi complex and between the cell surface and lipid bodies.
Pol A; Martin S; Fernández MA; Ingelmo-Torres M; Ferguson C; Enrich C; Parton RG
Mol Biol Cell; 2005 Apr; 16(4):2091-105. PubMed ID: 15689493
[TBL] [Abstract][Full Text] [Related]
2. Caveolin moves from caveolae to the Golgi apparatus in response to cholesterol oxidation.
Smart EJ; Ying YS; Conrad PA; Anderson RG
J Cell Biol; 1994 Dec; 127(5):1185-97. PubMed ID: 7962084
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of caveolin association with the Golgi complex: identification of a cis-Golgi targeting domain in the caveolin molecule.
Luetterforst R; Stang E; Zorzi N; Carozzi A; Way M; Parton RG
J Cell Biol; 1999 Jun; 145(7):1443-59. PubMed ID: 10385524
[TBL] [Abstract][Full Text] [Related]
4. Dynamic and regulated association of caveolin with lipid bodies: modulation of lipid body motility and function by a dominant negative mutant.
Pol A; Martin S; Fernandez MA; Ferguson C; Carozzi A; Luetterforst R; Enrich C; Parton RG
Mol Biol Cell; 2004 Jan; 15(1):99-110. PubMed ID: 14528016
[TBL] [Abstract][Full Text] [Related]
5. Tuberin is a component of lipid rafts and mediates caveolin-1 localization: role of TSC2 in post-Golgi transport.
Jones KA; Jiang X; Yamamoto Y; Yeung RS
Exp Cell Res; 2004 May; 295(2):512-24. PubMed ID: 15093748
[TBL] [Abstract][Full Text] [Related]
6. Annexin A6-induced alterations in cholesterol transport and caveolin export from the Golgi complex.
Cubells L; Vilà de Muga S; Tebar F; Wood P; Evans R; Ingelmo-Torres M; Calvo M; Gaus K; Pol A; Grewal T; Enrich C
Traffic; 2007 Nov; 8(11):1568-89. PubMed ID: 17822395
[TBL] [Abstract][Full Text] [Related]
7. A caveolin dominant negative mutant associates with lipid bodies and induces intracellular cholesterol imbalance.
Pol A; Luetterforst R; Lindsay M; Heino S; Ikonen E; Parton RG
J Cell Biol; 2001 Mar; 152(5):1057-70. PubMed ID: 11238460
[TBL] [Abstract][Full Text] [Related]
8. N-terminal protein acylation confers localization to cholesterol, sphingolipid-enriched membranes but not to lipid rafts/caveolae.
McCabe JB; Berthiaume LG
Mol Biol Cell; 2001 Nov; 12(11):3601-17. PubMed ID: 11694592
[TBL] [Abstract][Full Text] [Related]
9. Caveolin cycles between plasma membrane caveolae and the Golgi complex by microtubule-dependent and microtubule-independent steps.
Conrad PA; Smart EJ; Ying YS; Anderson RG; Bloom GS
J Cell Biol; 1995 Dec; 131(6 Pt 1):1421-33. PubMed ID: 8522601
[TBL] [Abstract][Full Text] [Related]
10. Caveolin interacts with the angiotensin II type 1 receptor during exocytic transport but not at the plasma membrane.
Wyse BD; Prior IA; Qian H; Morrow IC; Nixon S; Muncke C; Kurzchalia TV; Thomas WG; Parton RG; Hancock JF
J Biol Chem; 2003 Jun; 278(26):23738-46. PubMed ID: 12692121
[TBL] [Abstract][Full Text] [Related]
11. Aberrant dysferlin trafficking in cells lacking caveolin or expressing dystrophy mutants of caveolin-3.
Hernández-Deviez DJ; Martin S; Laval SH; Lo HP; Cooper ST; North KN; Bushby K; Parton RG
Hum Mol Genet; 2006 Jan; 15(1):129-42. PubMed ID: 16319126
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of lipid raft-dependent signaling by a dystrophy-associated mutant of caveolin-3.
Carozzi AJ; Roy S; Morrow IC; Pol A; Wyse B; Clyde-Smith J; Prior IA; Nixon SJ; Hancock JF; Parton RG
J Biol Chem; 2002 May; 277(20):17944-9. PubMed ID: 11884389
[TBL] [Abstract][Full Text] [Related]
13. Early proteostasis of caveolins synchronizes trafficking, degradation, and oligomerization to prevent toxic aggregation.
Morales-Paytuví F; Fajardo A; Ruiz-Mirapeix C; Rae J; Tebar F; Bosch M; Enrich C; Collins BM; Parton RG; Pol A
J Cell Biol; 2023 Sep; 222(9):. PubMed ID: 37526691
[TBL] [Abstract][Full Text] [Related]
14. Golgi Distribution of Lyn to Caveolin- and Giantin-Positive cis-Golgi Membranes and the Caveolin-Negative, TGN46-Positive trans-Golgi Network.
Okamoto A; Morinaga T; Yamaguchi N; Yamaguchi N
Biol Pharm Bull; 2018; 41(1):142-146. PubMed ID: 29311477
[TBL] [Abstract][Full Text] [Related]
15. Conformational defects slow Golgi exit, block oligomerization, and reduce raft affinity of caveolin-1 mutant proteins.
Ren X; Ostermeyer AG; Ramcharan LT; Zeng Y; Lublin DM; Brown DA
Mol Biol Cell; 2004 Oct; 15(10):4556-67. PubMed ID: 15304521
[TBL] [Abstract][Full Text] [Related]
16. Trafficking of Lyn through the Golgi caveolin involves the charged residues on alphaE and alphaI helices in the kinase domain.
Kasahara K; Nakayama Y; Ikeda K; Fukushima Y; Matsuda D; Horimoto S; Yamaguchi N
J Cell Biol; 2004 Jun; 165(5):641-52. PubMed ID: 15173188
[TBL] [Abstract][Full Text] [Related]
17. A distinct class of endosome mediates clathrin-independent endocytosis to the Golgi complex.
Nichols BJ
Nat Cell Biol; 2002 May; 4(5):374-8. PubMed ID: 11951093
[TBL] [Abstract][Full Text] [Related]
18. The caveolin triad: caveolae biogenesis, cholesterol trafficking, and signal transduction.
Schlegel A; Lisanti MP
Cytokine Growth Factor Rev; 2001 Mar; 12(1):41-51. PubMed ID: 11312118
[TBL] [Abstract][Full Text] [Related]
19. The scaffolding domain of caveolin 2 is responsible for its Golgi localization in Caco-2 cells.
Breuza L; Corby S; Arsanto JP; Delgrossi MH; Scheiffele P; Le Bivic A
J Cell Sci; 2002 Dec; 115(Pt 23):4457-67. PubMed ID: 12414992
[TBL] [Abstract][Full Text] [Related]
20. Assembly and trafficking of caveolar domains in the cell: caveolae as stable, cargo-triggered, vesicular transporters.
Tagawa A; Mezzacasa A; Hayer A; Longatti A; Pelkmans L; Helenius A
J Cell Biol; 2005 Aug; 170(5):769-79. PubMed ID: 16129785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
